SOUTH PLAINFIELD, N.J. & CAMBRIDGE, Mass. -- PTC Therapeutics, Inc. and Genzyme Corporation (Nasdaq: GENZ) today announced preliminary results from the Phase 2b clinical trial of ataluren, an investigational new drug, in patients with nonsense mutation Duchenne/Becker Muscular Dystrophy (nmDBMD

read more>>

WASHINGTON -- Members of America's Prostate Cancer Organizations are concerned that the issuance this morning of yet another set of new guidelines on screening for prostate cancer is only adding to the confusion most men already feel about whether they should or shouldn't be tested for the most "I

read more>>

SEATTLE -- Dendreon Corporation (Nasdaq: DNDN) today announced updated results from its pivotal Phase 3 IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study demonstrating that PROVENGE® (sipuleucel-T) extends overall survival in men with metastatic, castrate-resistant (hormone-Th

read more>>

BRIDGEWATER -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today results from a Phase 3 trial which demonstrated cabazitaxel, an investigational compound, plus prednisone/prednisolone significantly improved overall survival and progression-free survival in patients with metastatic (The

read more>>

LONDON -- Beneficial Alzheimer's therapies that don't use drugs, and an update on prevention efforts, are the focus of the second day's plenary sessions at the 25th International Conference of Alzheimer's Disease International (ADI), March 12, 2010 at the Grand Hotel Palace, Thessaloniki, GreecePr

read more>>

Researchers at the University of Cincinnati have found that using high-resolution CT-scans to screen for lymphangioleiomyomatosis, or LAM, is cost-effective in non-smoking women between 25 and 54 who come to the emergency room for the first time with a collapsed lungThe findings have been publishe

read more>>

New York, NY --  Television celebrity Gregory Itzin, best known for his role as President Charles Logan on FOX's primetime drama '24,' recently donated his time to create a radio public service announcement (PSA) series on behalf of the Crohn's & Colitis Foundation to raise critical The 6

read more>>

WASHINGTON -- A groundbreaking new report from the American Autoimmune Related Diseases Association (AARDA), examining the current state of autoimmune disease (AD) and its economic and social impact globally and in the U.S., was released today at the National Autoimmune Diseases Summit: The Global

read more>>

SALT LAKE CITY -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced the launch of PROLARIS(TM), a 46-gene prognostic test which quantitatively determines the risk of recurrence in patients who have undergone prostatectomy surgeryFor the first time, physicians now have a direct molecular measure

read more>>

JERSEY CITY, N.J. -- Lux Biosciences, Inc. today announced that the European Medicines Agency (EMA) has accepted the filing of the company’s Marketing Authorization Application (MAA) for the company’s lead product, Luveniq™ (LX211; oral voclosporin) for the treatment of Lux previ

read more>>